Treatment of inflammatory bowel disease: a comprehensive review
Z Cai, S Wang, J Li - Frontiers in medicine, 2021 - frontiersin.org
Inflammatory bowel disease (IBD), as a global disease, has attracted much research
interest. Constant research has led to a better understanding of the disease condition and …
interest. Constant research has led to a better understanding of the disease condition and …
Crohn disease: epidemiology, diagnosis, and management
Crohn disease is a chronic idiopathic inflammatory bowel disease condition characterized
by skip lesions and transmural inflammation that can affect the entire gastrointestinal tract …
by skip lesions and transmural inflammation that can affect the entire gastrointestinal tract …
Resolution of chronic inflammatory disease: universal and tissue-specific concepts
G Schett, MF Neurath - Nature communications, 2018 - nature.com
Inflammation and its resolution is under-studied in medicine despite being essential for
understanding the development of chronic inflammatory disease. In this review article, we …
understanding the development of chronic inflammatory disease. In this review article, we …
Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta-analysis
Objectives We sought to evaluate the association between obesity and response to anti-
tumor necrosis factor-α (TNF) agents, through a systematic review and meta-analysis …
tumor necrosis factor-α (TNF) agents, through a systematic review and meta-analysis …
[HTML][HTML] Immune checkpoint Inhibitor–Induced diarrhea and Colitis: Incidence and Management. A systematic review and Meta-analysis
DL Nielsen, CB Juhl, IM Chen, L Kellermann… - Cancer Treatment …, 2022 - Elsevier
Abstract Background Immune checkpoint inhibitors (ICIs) have improved cancer outcomes.
However, immune-related adverse effects are common. The aim was to investigate the …
However, immune-related adverse effects are common. The aim was to investigate the …
Ulcerative colitis: epidemiology, diagnosis, and management
Ulcerative colitis is a chronic idiopathic inflammatory bowel disease characterized by
continuous mucosal inflammation that starts in the rectum and extends proximally. Typical …
continuous mucosal inflammation that starts in the rectum and extends proximally. Typical …
Systematic review and network meta‐analysis: first‐and second‐line biologic therapies for moderate‐severe Crohn's disease
Background There are limited data to inform positioning of agents for treating moderate‐
severe Crohn's disease (CD). Aim We assessed comparative efficacy and safety of first‐line …
severe Crohn's disease (CD). Aim We assessed comparative efficacy and safety of first‐line …
Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammatory bowel diseases: a …
Abstract Background and Aims We sought to analyze whether response to a second-line
biologic varies depending on the reason for discontinuation of the primary anti-TNF agent …
biologic varies depending on the reason for discontinuation of the primary anti-TNF agent …
[HTML][HTML] Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis
Background & Aims Biologics are used routinely in pregnant women with inflammatory
bowel disease (IBD), but large-scale data reporting adverse pregnancy outcomes among …
bowel disease (IBD), but large-scale data reporting adverse pregnancy outcomes among …
[HTML][HTML] Histamine and T helper cytokine–driven epithelial barrier dysfunction in allergic rhinitis
Background Allergic rhinitis (AR) is characterized by mucosal inflammation, driven by
activated immune cells. Mast cells and TH 2 cells might decrease epithelial barrier integrity …
activated immune cells. Mast cells and TH 2 cells might decrease epithelial barrier integrity …